Literature DB >> 14520661

Predictors of neuropathological severity in 100 patients with Huntington's disease.

Adam Rosenblatt1, Margaret H Abbott, Lisa M Gourley, Juan C Troncoso, Russell L Margolis, Jason Brandt, Christopher A Ross.   

Abstract

Subjects were followed in the Longitudinal Core Study of the Baltimore Huntington's Disease Center and given annual neurological, cognitive, and psychiatric examinations. Postmortem neuropathological grade was assigned using the system of Vonsattel and colleagues. We examined the correlations between the neuropathological grade and scores on the Quantified Neurological Examination (QNE) and its chorea and motor impairment subscales, the Mini-Mental State Examination (MMSE), the HD Activities of Daily Living (ADL) Scale, and a number of demographic variables (CAG number, age of onset, age at death, disease duration) in 100 subjects who had been examined within 1,000 days of death. All measures showed significant correlation with Vonsattel score except for chorea. The strongest effect was that of motor impairment score (r(2) = 0.351, p < 0.0001). In a stepwise correlation of clinical variables, motor impairment remained significant. The largest effect for a demographic variable was for age of onset (r(2) = 0.226, p < 0.0001) A partial correlation was significant between CAG number and Vonsattel grade, controlling for age at death or disease duration. Motor impairment appears to be a good clinical measure of neuronal cell loss, at least late in the course of HD and therefore may prove useful in observational and treatment studies.

Entities:  

Mesh:

Year:  2003        PMID: 14520661     DOI: 10.1002/ana.10691

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts?

Authors:  W Becker; R Jürgens; J Kassubek; D Ecker; B Kramer; B Landwehrmeyer
Journal:  Exp Brain Res       Date:  2008-09-20       Impact factor: 1.972

3.  Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease.

Authors:  Zhihong Guo; Gay Rudow; Olga Pletnikova; Kari-Elise Codispoti; Brent A Orr; Barbara J Crain; Wenzhen Duan; Russell L Margolis; Adam Rosenblatt; Christopher A Ross; Juan C Troncoso
Journal:  Mov Disord       Date:  2012-09-13       Impact factor: 10.338

4.  Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.

Authors:  Ivan Tkac; Janet M Dubinsky; C Dirk Keene; Rolf Gruetter; Walter C Low
Journal:  J Neurochem       Date:  2007-01-08       Impact factor: 5.372

Review 5.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

6.  Expression analysis of novel striatal-enriched genes in Huntington disease.

Authors:  Gelareh Mazarei; Scott J Neal; Kristina Becanovic; Ruth Luthi-Carter; Elizabeth M Simpson; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

Review 7.  Focal nature of neurological disorders necessitates isotype-selective histone deacetylase (HDAC) inhibitors.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2009-04-28       Impact factor: 5.590

Review 8.  Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Authors:  Christopher A Ross; Alex Pantelyat; Jane Kogan; Jason Brandt
Journal:  Mov Disord       Date:  2014-09-15       Impact factor: 10.338

9.  Survival of Huntington's disease patients in Serbia: longer survival in female patients.

Authors:  Tatjana Pekmezovic; Marina Svetel; Jelena Maric; Irena Dujmovic-Basuroski; Natasa Dragasevic; Milica Keckarevic; Stanka Romac; Vladimir S Kostic
Journal:  Eur J Epidemiol       Date:  2007-07-25       Impact factor: 8.082

10.  Lewy bodies and neuronal loss in subcortical areas and disability in non-demented older people: a population based neuropathological cohort study.

Authors:  M Byford; C Brayne; I McKeith; M Chatfield; Pg Ince; Fe Matthews
Journal:  BMC Geriatr       Date:  2009-06-15       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.